Insider · CIK 0001415537

Iwicki Mark T

CIK 0001415537 Name as filed on the most recent filing

Filed as Iwicki Mark T (17)

17 transaction lines · from 17 filings · filed 2015-08-11 to 2025-10-24 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

17 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-10-23 S, Open-market sale Kala BIO, Inc.KALA 125,464, disposed Open Form 4 filing 0001415537-25-000004
2025-06-24 S, Open-market sale Kala BIO, Inc.KALA 53,040, disposed Open Form 4 filing 0001415889-25-018317
2025-06-03 S, Open-market sale Kala BIO, Inc.KALA 40,639, disposed Open Form 4 filing 0001104659-25-056986
2025-06-03 S, Open-market sale Kala BIO, Inc.KALA 40,639, acquired Open Form 4 filing 0001415889-25-015677
2025-01-06 S, Open-market sale Kala BIO, Inc.KALA 44,094, disposed Open Form 4 filing 0001415889-25-001060
2024-06-26 S, Open-market sale Kala BIO, Inc.KALA 72,048, disposed Open Form 4 filing 0001415889-24-018374
2024-05-31 S, Open-market sale Kala BIO, Inc.KALA 45,017, disposed Open Form 4 filing 0001415889-24-015222
2024-01-04 S, Open-market sale Kala BIO, Inc.KALA 30,547, disposed Open Form 4 filing 0001415889-24-000769
2023-01-04 S, Open-market sale Kala Pharmaceuticals, Inc.KALA 5,651, disposed Open Form 4 filing 0001415889-23-000636
2022-10-26 S, Open-market sale Kala Pharmaceuticals, Inc.KALA 3,658, disposed Open Form 4 filing 0001415889-22-010878
2022-06-27 S, Open-market sale Kala Pharmaceuticals, Inc.KALA 2,951, disposed Open Form 4 filing 0001415889-22-007059
2022-01-04 S, Open-market sale Kala Pharmaceuticals, Inc.KALA 12,373, disposed Open Form 4 filing 0001415889-22-000402
2021-10-26 S, Open-market sale Kala Pharmaceuticals, Inc.KALA 49,676, disposed Open Form 4 filing 0001415889-21-005009
2021-06-28 S, Open-market sale Kala Pharmaceuticals, Inc.KALA 43,771, disposed Open Form 4 filing 0001415889-21-003256
2018-04-03 P, Open-market purchase Pulmatrix, Inc.PULM Not reported Open Form 4 filing 0000899243-18-009609
2018-02-26 P, Open-market purchase Aimmune Therapeutics, Inc.AIMT 300,000, acquired Open Form 4 filing 0000899243-18-005465
2015-08-11 P, Open-market purchase Aimmune Therapeutics, Inc.AIMT 320,000, acquired Open Form 4 filing 0000899243-15-002781

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 3
  • Open-market sale 14
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Iwicki Mark T, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001415537

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.